NCT00368823

Brief Summary

Does presentation of clinical evidence for decision making at point-of-care improve prescribing patterns in ambulatory pediatrics?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Nov 1999

Typical duration for phase_3

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 1999

Completed
4.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2003

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

August 24, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 29, 2006

Completed
Last Updated

August 29, 2006

Status Verified

August 1, 2006

First QC Date

August 24, 2006

Last Update Submit

August 24, 2006

Conditions

Keywords

point of careevidence based medicine

Outcome Measures

Primary Outcomes (8)

  • prescribing practices for acute otitis media,

  • allergic rhinitis,

  • sinusitis,

  • constipation,

  • pharyngitis,

  • croup,

  • urticaria,

  • bronchiolitis

Interventions

Eligibility Criteria

Age0 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Roosevelt Pediatric Clinic

Seattle, Washington, United States

Location

Skagit Valley Pediatrics

Skagit Valley, Washington, United States

Location

MeSH Terms

Conditions

Otitis MediaRhinitis, AllergicSinusitisConstipationPharyngitisCroupUrticariaBronchiolitis

Condition Hierarchy (Ancestors)

OtitisEar DiseasesOtorhinolaryngologic DiseasesRhinitisNose DiseasesRespiratory Tract DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesRespiratory Tract InfectionsInfectionsParanasal Sinus DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsPharyngeal DiseasesStomatognathic DiseasesLaryngitisLaryngeal DiseasesSkin Diseases, VascularSkin DiseasesSkin and Connective Tissue DiseasesBronchitisBronchial DiseasesLung Diseases, ObstructiveLung Diseases

Study Officials

  • Robert L Davis, MD, MPH

    University of Washington

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 24, 2006

First Posted

August 29, 2006

Study Start

November 1, 1999

Study Completion

December 1, 2003

Last Updated

August 29, 2006

Record last verified: 2006-08

Locations